Disease

Hepatitis, Autoimmune

Late-stage therapeutic developmentEmerging research

MeSHHepatitis, Autoimmune

Publications

Clinical trials

2020

Latest publication

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

Research2020-05-12Hepatology (Baltimore, Md.)

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

4 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme

All trials

Active

Late-stage

Completed

Late-stage studies

DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL WITH CHLOROQUINE VERSUS PLACEBO FOR MAINTENANCE OF REMISSION OF AUTOIMMUNE HEPATITIS

Phase 4 · Completed · University of Sao Paulo General Hospital

Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Treatment of Auto-immune Hepatitis

Phase 3 · Withdrawn · Xiaoli Fan

Recently completed

DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL WITH CHLOROQUINE VERSUS PLACEBO FOR MAINTENANCE OF REMISSION OF AUTOIMMUNE HEPATITIS

Phase 4 · Completed · University of Sao Paulo General Hospital

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

Hepatology (Baltimore, Md.) · 2020 · 615 cites

Recent publications

Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

Hepatology (Baltimore, Md.) · 2020 · 615 cites

Leading journals1

Hepatology (Baltimore, Md.)1

Leading researchers8

Adams D1
Alsawas M1
Assis DN1
Czaja AJ1
Kerkar N1
Mack CL1
Manns MP1
Mayo MJ1

Affiliations (unnormalised)6

Baylor College of Medicine1
Centre for Liver Research1
Golisano Children's Hospital at Strong1
Hannover Medical School1
Mayo Clinic College of Medicine1
Mayo Clinic Minnesota1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.

Identifiers

MeSHHepatitis, Autoimmune

References & data sources

Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
Related entities are derived from literature co-mention (studied together) — associative, not causal.